← All trials
NCT03485417
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2018
- Primary completion
- Dec 30, 2021
- Completion date
- Mar 31, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 240
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- The University of Hong KongLead sponsor
- The University of Hong KongReponsible party - principal investigator
- The University of Hong KongCollaborator
- North District HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.